http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GR-1009550-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_22440ee0c89c48b5babfff1942fd8b08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5447fd4968e7b1dd3c523ad29a413bc6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f5c8f47a489a3af3dabb7aaf03621f37 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F1-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-498 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F1-08 |
| filingDate | 2018-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b93f07bbdb0c898b86a24a0943e16e18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa3aaa95b6250398bb632a54f6398a69 |
| publicationDate | 2019-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GR-1009550-B |
| titleOfInvention | UNCONSTRUCTED COPPER ASSOCIATIONS WITH NATURAL PRODUCTS OF PYRIDYLOKINOXALINE AND NITRATES SHOWING ANTI-CANCER AND ANTI-FUNCTION DRUS AND DRUGS |
| abstract | The present invention relates to the discovery of two novel complexes of divalent copper with substituents 2,2D-pyridyl quinoxaline (2,2D-pq) and nitrates and the method of their preparation in high yield, high purity and crystalline form. More specifically the compounds synthesized are [Cu (2,2΄-pq) 2 (NO3)] (NO3) -6H2O, 1-A and [Cu (2,2΄-pq) (NO3)] (NO3) , II-A. The present invention also provides methods of identifying the crystal structure of the biologically active complex I-A, as well as methods of action of the compounds [Cu (2,2΄-pq) (NO3)] (NO3) and [Cu (2,2΄- pq) 2 (NO3)] (NO3) -6H2O to certify their ability to act as multidrugs, both anticancer and antifungal. Reference is also made to the mode of action of these compounds with the DNA with which they interact through interference and external coupling, but also their effect on the cell or cytoplasm. As well as their ability to be used as multi-purpose drugs, to avoid polypharmacy. |
| priorityDate | 2018-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.